HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kocazeybek, B. Search for Related Content PubMed PubMed Citation Articles by Kocazeybek, B. Agricola Articles by Kocazeybek, B.

Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case–control study

Cerrahpaa Faculty of Medicine, Istanbul University, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey

Correspondence Bekir Kocazeybek bekirkcz{at}superonline.com

Received December 3, 2001
Accepted January 21, 2003

The relationship between chronic Chlamydophila (formerly Chlamydia) pneumoniae infection and lung carcinoma was investigated. A total of 123 patients who were smokers and diagnosed with lung carcinoma based on clinical and laboratory (radiological, cytological) findings were examined. Of these patients, 70 had small-cell, 28 squamous-cell and seven large-cell carcinomas, while 18 had adenocarcinoma. A total of 123 healthy persons matching patients in age, sex, duration of smoking and locality were chosen as controls. Blood samples (5 ml) were withdrawn at the time of diagnosis and 1 month later. The values between IgG 512 and IgA 40 were set as the criteria for chronic Chlamydophila pneumoniae infections. In male patients with lung carcinoma, Chlamydophila pneumoniae IgG antibody titres of 512 and IgA antibody titres of 40 were found at a higher rate than in the control group. This ratio was not significant for the female patients. In chronic Chlamydophila pneumoniae infections, Chlamydophila pneumoniae antibody titres with values IgG 512 and IgA 40 were found in a total of 62 (50.4 %) cases. Chronic Chlamydophila pneumoniae infections were seen statistically more often in male patients with carcinoma who were aged 55 years or younger. This study supports the idea that chronic Chlamydophila pneumoniae infection increases the risk of lung carcinoma.

This article has been cited by other articles:

				H. Zhang, L. A. Garcia Rodriguez, and S. Hernandez-Diaz Antibiotic Use and the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1308 - 1315. [Abstract] [Full Text] [PDF]

				T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719. [Abstract] [Full Text] [PDF]

				A. J. Littman, L. A. Jackson, and T. L. Vaughan Chlamydia pneumoniae and Lung Cancer: Epidemiologic Evidence Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 773 - 778. [Abstract] [Full Text] [PDF]

				A. J. Littman, E. White, L. A. Jackson, M. D. Thornquist, C. A. Gaydos, G. E. Goodman, and T. L. Vaughan Chlamydia pneumoniae Infection and Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1624 - 1630. [Abstract] [Full Text] [PDF]

				S. Altun, O. Kasapcopur, M. Aslan, S. Karaarslan, V. Koksal, S. Saribas, S. Ergin, N. Arisoy, and B. Kocazeybek Is there any relationship between Chlamydophila pneumoniae infection and juvenile idiopathic arthritis? J. Med. Microbiol., August 1, 2004; 53(8): 787 - 790. [Abstract] [Full Text] [PDF]